Citisina, medicamento eficaz de costo bajo para dejar de fumar que debe estar disponible en todos los países latinoamericanos

Contenido principal del artículo

Rogelio Pérez Padilla
https://orcid.org/0000-0002-1132-5308
Gustavo Zabert

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Cómo citar
Pérez Padilla, R., & Zabert, G. (2023). Citisina, medicamento eficaz de costo bajo para dejar de fumar que debe estar disponible en todos los países latinoamericanos. Respirar, 15(4). https://doi.org/10.55720/respirar.15.4.1
Sección
Editoriales

Citas

Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2016;2016(5):Cd006103. Doi: 10.1002/14651858.CD006103.pub7.

Tutka P, Vinnikov D, Courtney RJ, Benowitz NL. Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation. Addiction 2019;114(11):1951-69. Doi: 10.1111/add.14721.

Walker N, Howe C, Glover M et al. Cytisine versus nicotine for smoking cessation. N Engl J Med 2014;371(25):2353-62. Doi: 10.1056/NEJMoa1407764.

Hajek P, McRobbie H, Myers K. Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis. Thorax 2013;68(11):1037-42. Doi: 10.1136/thoraxjnl-2012-203035.

Prochaska JJ, Das S, Benowitz NL. Cytisine, the world's oldest smoking cessation aid. BMJ 2013;347:f5198. Doi: 10.1136/bmj.f5198.

Walker N, Smith B, Barnes J et al. Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial. Addiction 2021;116(10):2847-58. Doi: 10.1111/add.15489.

Courtney RJ, McRobbie H, Tutka P, et al. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial. JAMA 2021;326(1):56-64. Doi: 10.1001/jama.2021.7621.

Leaviss J, Sullivan W, Ren S et al. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation. Health Technol Assess 2014;18(33):1-120. Doi: 10.3310/hta18330.

Thomas D, Farrell M, McRobbie H et al. The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial. Addiction 2019;114(5):923-33. Doi: 10.1111/add.14541.

FDA. Select-Lot Varenicline Recall 2021. [Internet]. [Consultado 6 Ago 2022]. Disponible en: https://http://www.cdc.gov/tobacco/campaign/tips/quit-smoking/quit-smoking-medications/varenicline-recall/index.html.

Thirion-Romero I, Pérez-Padilla R, Zabert G, Barrientos-Gutierrez I. Respiratory impact of electronic cigarettes and low-risk tobacco. Revista de Investigación Clínica 2019;71(1):17–27. Doi:10.24875/RIC.18002616.

Artículos más leídos del mismo autor/a